LRWA
Long Run Wealth Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-106,278
| Closed | -$3.59M | – | 104 |
|
|
2024
Q4 | $3.59M | Buy |
106,278
+20,355
| +24% | +$688K | 0.86% | 38 |
|
|
2024
Q3 | $3.51M | Buy |
85,923
+3,380
| +4% | +$138K | 0.83% | 39 |
|
|
2024
Q2 | $3.18M | Buy |
82,543
+1,537
| +2% | +$59.2K | 0.8% | 37 |
|
|
2024
Q1 | $3.47M | Buy |
81,006
+2,786
| +4% | +$119K | 0.91% | 33 |
|
|
2023
Q4 | $2.9M | Buy |
78,220
+6,401
| +9% | +$237K | 0.84% | 34 |
|
|
2023
Q3 | $2.6M | Buy |
71,819
+4,664
| +7% | +$169K | 0.84% | 31 |
|
|
2023
Q2 | $2.39M | Buy |
67,155
+4,708
| +8% | +$168K | 0.76% | 37 |
|
|
2023
Q1 | $2.22M | Buy |
+62,447
| New | +$2.22M | 0.76% | 39 |
|